• 503Pharma
  • Posts
  • 503Pharma Weekly Compounding Pharmacy Roundup

503Pharma Weekly Compounding Pharmacy Roundup

Your trusted source for compounding pharmacy education, news and insights.

1. Get Your Pharmacy listed in our Free Directory!

Thousands of providers and patients are searching for trusted compounders every day.

We’re building the most complete, nationwide directory of 503A and 503B compounding pharmacies — and we want your pharmacy listed. It’s free, takes less than 2 minutes, and helps boost your pharmacy’s visibility.

Add your pharmacy profile to CompoundingPharmaciesNearMe.com now!

2. News & Regulatory Updates

  • Hims & Hers Reports Record Growth and Novo Nordisk Partnership Talks:
    Hims & Hers Health (HIMS) reported Q3 2025 revenue of $599 million (+49% YoY) and reached 2.47 million subscribers (+21% YoY). The company confirmed active discussions with Novo Nordisk to offer both Wegovy injections and future oral Wegovy on its platform — a potential entry into the booming GLP-1 weight-loss drug market. https://investors.hims.com/news/news-details/2025/Hims--Hers-Health-Inc--Reports-Third-Quarter-2025-Financial-Results/

  • NABP Inspections Flag USP <797> Violations in Sterile Compounding: Pharmacy Practice News report on the National Association of Boards of Pharmacy's (NABP) latest hospital inspections shows overall strong compliance scores but persistent issues like dead geckos in cleanrooms, techs compounding with makeup/fake nails, and inadequate immediate-use documentation. https://www.pharmacypracticenews.com/Policy/Article/11-25/Pharmacy-Compliance-Inspection-Findings/78766

  • Chester County pharmacy fined $1M for compounding GLP-1 medications in uninspected facilities: On October 21, 2025, Pennsylvania Department of State announced that a Chester County Pharmacy agreed to pay a $1 million civil penalty and accept probation of its pharmacy permit through January 31, 2028, after investigators found it had compounded and distributed approximately 30,000 doses of injectable weight‑loss drugs without valid patient‑specific prescriptions, in uninspected and unapproved facilities.

3. Stress-Free, Efficient Compliance Training

Tired of manual training tracking, compliance gaps, and dreading state board inspections? 503Pharma is launching CompoundLearn - the first Learning Management System (LMS) built specifically for compounding pharmacies. Join our waitlist for exclusive early access!

  • Never fail another inspection - Automated USP 795/797 documentation and training content with real-world scenarios

  • Eliminate spreadsheet hell - Real-time dashboard shows exactly who needs what training when

  • Stop losing sleep over deadlines - Automated reminders and certificate renewals

Request Free Compounding Formulas

✉️ That’s your 503Pharma weekly digest. Our mission is to keep compounding professionals informed, prepared, and ahead of the curve.